Aion Therapeutic Inc.
ANTCFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2072064
P/E Ratio—
52W High$0.0197
52W Low$0.0013
Aion Therapeutic Inc. (ANTCF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ANTCF · earnings · updated Jun 10, 2026
Latest Earnings
Q4 FY2023Report Date: Oct 31, 2023EPS Actual
-$0.00
Revenue
—
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Oct 31, 2023
After Market Close
ANTCF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2023 | Oct 31, 2023 | — | -$0.00 | — | — | — | — |
| — Q3 FY2023 | Jul 31, 2023 | — | -$0.00 | — | — | — | — |
| — Q2 FY2023 | Apr 30, 2023 | — | -$0.00 | — | — | — | — |
| — Q1 FY2023 | Jan 31, 2023 | — | -$0.00 | — | — | — | — |
| — Q4 FY2022 | Oct 31, 2022 | — | -$0.00 | — | — | — | — |
| — Q3 FY2022 | Jul 31, 2022 | — | $0.00 | — | — | — | — |
| — Q2 FY2022 | Apr 30, 2022 | — | -$0.01 | — | — | — | — |
| — Q1 FY2022 | Jan 31, 2022 | — | -$0.00 | — | — | — | — |
Q4 FY2023
Oct 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Jul 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
Apr 30, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Jan 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Oct 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2022
Jul 31, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2022
Apr 30, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2022
Jan 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for ANTCF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Oct 31, 2023 | — | $0.00 | — | — |
| — Q3 FY2023 | Jul 31, 2023 | — | $0.00 | $0.01 | +177.78% |
| — Q2 FY2023 | Apr 30, 2023 | — | $0.00 | $0.01 | +66.67% |
| — Q1 FY2023 | Jan 31, 2023 | — | $0.00 | $0.01 | +212.50% |
| — Q4 FY2022 | Oct 31, 2022 | — | $0.01 | $0.01 | -15.38% |
| — Q3 FY2022 | Jul 31, 2022 | — | $0.03 | $0.03 | +0.00% |
| — Q2 FY2022 | Apr 30, 2022 | — | $0.01 | $0.01 | -36.04% |
| — Q1 FY2022 | Jan 31, 2022 | — | No price data | $0.02 | — |
Q4 FY2023—
Report Date
Oct 31, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
—
Q3 FY2023+177.78%
Report Date
Jul 31, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q2 FY2023+66.67%
Report Date
Apr 30, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q1 FY2023+212.50%
Report Date
Jan 31, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q4 FY2022-15.38%
Report Date
Oct 31, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2022+0.00%
Report Date
Jul 31, 2022
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q2 FY2022-36.04%
Report Date
Apr 30, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2022—
Report Date
Jan 31, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$0.02
Beat Rate0 / 8 quarters
Largest Move+212.50% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ANTCF ends December
Aion Therapeutic Inc. (ANTCF) most recently reported earnings on October 31, 2023 for Q4 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —).
Each quarter, investors track ANTCF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ANTCF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ANTCF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ANTCF earnings · 4 questionsAion Therapeutic Inc.'s next earnings report is expected around TBD. ANTCF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ANTCF historically reports after market close (AMC).
ANTCF earnings datewhen is ANTCF earningsANTCF next earnings datewhen does ANTCF report earningsANTCF earnings calendar
▸ Source: FMP · Aion Therapeutic Inc. SEC filings · US GAAP · Aion Therapeutic Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026